“Treatment Outcome in Patients With HCV Genotype-3a Infection, Treated With 24-Weeks Dual Therapy (Sofosbuvir and Ribavirin)”. 2024. Medical Forum Monthly 28 (11). https://medicalforummonthly.com/index.php/mfm/article/view/4275.